NDAINTRA-ARTERIALSOLUTION
Approved
Nov 2024
Lifecycle
Growth
Competitive Pressure
18/100
Mechanism of Action
X-Ray Contrast Activity
Pharmacologic Class:
Radiographic Contrast Agent
Loss of Exclusivity
LOE Date
Nov 27, 2029
45 months away
Exclusivity Expiry
Nov 27, 2029
Company
Bracco
Italy - Milan
External Resources